Search Results
Showing results 1 to 20 of 33.
Article
Cost-effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) gene therapy for patients with sickle cell disease and recurrent vaso-occlusive events in the United States
June 01, 2024
Article
People get ready! A new generation of Alzheimer's therapies may require new ways to deliver and pay for healthcare
March 01, 2024
Article
Evaluating elements of the care partner experience in individuals who care for people with Alzheimer's disease across the severity spectrum
February 01, 2024
Article
Going forward: Potential impact of protein-based COVID-19 vaccination coverage on population outcomes and costs in the United States
January 12, 2024
Article
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom
January 01, 2024
Article
Use of patient-reported outcomes as key drivers in cost-effectiveness models: A review of UK National Institute for Health and Care excellence Health Technology assessments
June 01, 2023
Article
Relationships among sickle cell disease complications and their implications for Cost-Effectiveness modeling for therapies with Curative intent
June 01, 2023
Article
Cost-effectiveness models for Alzheimer's disease and related dementias: IPECAD modeling workshop cross-comparison challenge
May 01, 2023
Article
Cost-effectiveness of respiratory syncytial virus preventive interventions in children: A model comparison study
April 01, 2023
Article
Evaluation of emerging NASH therapies: The impact of treatment efficacy profiles on long-term health outcomes
December 01, 2022
Article
Assessing the cost-effectiveness of the novavax COVID-19 vaccine as a potential booster vaccine option for adults in the United States
December 01, 2022
Article
Cost-effectiveness of respiratory syncytial virus (RSV) prevention interventions in children: A model comparison study
December 01, 2022
Article
The relationship between asthma control questionnaire scores and exacerbation risk, resource utilization, and utility values: An analysis from the captain trial
December 01, 2022
Article
What might have happened: The impact of interrupting entry of innovative drugs on disease outcomes in the United States
June 01, 2022
Article
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in patients with inadequate response to disease-modifying therapies in relapsing-remitting multiple sclerosis in the United Kingdom
March 01, 2022
Article
Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States
January 24, 2022
Article
Predicted lifetime health outcomes for aducanumab in patients with early Alzheimer's disease
December 01, 2021
Article
Estimated public health impact of the recombinant zoster vaccine
June 01, 2021
Article
Predicted delays in dementia onset for an innovative therapy acting on beta-amyloid in patients with mild cognitive impairment due to Alzheimer's disease
December 01, 2020
Article
Incremental clinical and economic impact of recombinant zoster vaccination: Real-world data in a budget impact model
December 01, 2020